Muffy wrote: CPAP creates the CompSAS scenario by changing the plant gain:
...Then, any ventilatory disturbance (including, for example, an arousal-producing PLM) starts The Loop.
The above ventilatory control-feedback loop is always going, although not always oscillating out of control. I think just about everyone in sleep science agrees that CPAP adversely increases CO2-based plant gain in the case of CSDB/CompSAS patients. I agree with that as well and I'm not even in sleep science! And I also think that just about everyone in sleep science agrees that when loop gain is greater than one, that ventilatory instability (controller oscillations) will occur in response to system perturbations.
However, short of the occasional message board innuendo, I don't think anyone in science claims to understand all possible pathogenic factors adversely increasing plant or controller gain. Admittedly some of those pathogenic factors directly responsible for increasing either type of loop gain are well understood by contemporary medicine. Forgetting about any undiscovered control-system inputs affecting ventilatory loop gain for a minute, have you noticed there are researchers who acknowledge that the above highly-useful loop-gain respiratory model falls down---fails to model---under certain circumstances? It's just a model. Part of what makes it so applicable is its simplicity. And generally speaking, simplistic models often fail to correctly model under a variety of circumstances.
I think we both agree how genuinely useful that ventilatory loop gain model is. But we seem to disagree on the unknown realm of pathogenic factors that might alter plant gain and controller gain. Science very clearly does not claim to completely understand all gain-affecting inputs.
My theoretical premise: certain unexplored neural stimuli can alter loop gain itself---in at least some neurologically disordered breathing types.
Then we agree that Rapoport's near-perfect specificity was relevant to his equipment and COS processing. And I think we also agree that heightened sensitivity can outstrip that near-perfect specificity in this biomedical application. Not much COS advancement in the white papers in the last ten years regarding central apnea differentiation... And that's undoubtedly because sensor and signal-processing refinement yield greater sensitivity, which deteriorates specificity in this particular biomedical application.Muffy wrote:My point 'zactly! Mary was using an $800 pneumotach.
__________________________________________________________________________________________________________________________________
Crowpat, I'm still with you. And I still have a variety of parameter-based pressure experimentation to propose. Please let me continue looking through all your data details to date...